PIN1 and hepatocellular carcinoma: Moreover, this impaired miRNA biogenesis in hepatocellular carcinoma could be restored by novel Pin1 inhibitors and their formulations (Pu et al., 2018; Fan et al., 2019; Sun et al., 2019; Zheng et al., 2019), giving new insight into the therapy of liver cancer.